Is Palantir Stock Going to Crash?
AI and data analytics major Palantir (NASDAQ:PLTR) has become something…
Sell
49
GEHC Quote, Financials, Valuation and Earnings
Last price:
$79.79
Seasonality move
:
4.15%
Day range:
$79.58 - $81.81
52-week range:
$57.65 - $94.80
Dividend yield:
0.18%
P/E ratio:
16.49x
P/S ratio:
1.81x
P/B ratio:
3.64x
Volume:
2.3M
Avg. volume:
3.1M
1-year change:
-9.52%
Market cap:
$36.3B
Revenue:
$19.7B
EPS (TTM):
$4.84
Analysts' Opinion
-
Consensus RatingGE Healthcare Technologies, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 6 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $92.00, GE Healthcare Technologies, Inc. has an estimated upside of 15.33% from its current price of $79.77.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $77.00 representing 3.47% downside risk from its current price of $79.77.
Fair Value
-
According to the consensus of 17 analysts, GE Healthcare Technologies, Inc. has 15.33% upside to fair value with a price target of $92.00 per share.
GEHC vs. S&P 500
-
Over the past 5 trading days, GE Healthcare Technologies, Inc. has underperformed the S&P 500 by -2.98% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
GE Healthcare Technologies, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
GE Healthcare Technologies, Inc. has grown year-over-year revenues for 6 quarters straight. In the most recent quarter GE Healthcare Technologies, Inc. reported revenues of $5.1B.
Earnings Growth
-
GE Healthcare Technologies, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter GE Healthcare Technologies, Inc. reported earnings per share of $0.98.
Enterprise value:
43.3B
EV / Invested capital:
--
Price / LTM sales:
1.81x
EV / EBIT:
14.94x
EV / Revenue:
2.14x
PEG ratio (5yr expected):
0.51x
EV / Free cash flow:
30.92x
Price / Operating cash flow:
26.11x
Enterprise value / EBITDA:
12.48x
Gross Profit (TTM):
$8.2B
Return On Assets:
6.65%
Net Income Margin (TTM):
11.31%
Return On Equity:
24.49%
Return On Invested Capital:
11.74%
Operating Margin:
13.55%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $19.3B | $19.6B | $20.2B | $4.9B | $5.1B | |
| Gross Profit | $7.6B | $8.1B | $8.2B | $2B | $2B | |
| Operating Income | $2.4B | $2.8B | $2.9B | $708M | $697M | |
| EBITDA | $3.1B | $3.4B | $3.5B | $851M | $846M | |
| Diluted EPS | $3.37 | $3.65 | $4.84 | $1.02 | $0.98 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $9.1B | $10.3B | $11.5B | |
| Total Assets | -- | -- | $32.4B | $33.9B | $36.1B | |
| Current Liabilities | -- | -- | $7.6B | $8.7B | $10.1B | |
| Total Liabilities | -- | -- | $25.1B | $25.3B | $25.9B | |
| Total Equity | -- | -- | $7.3B | $8.5B | $10.2B | |
| Total Debt | -- | -- | $10.3B | $9.6B | $8.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.1B | $2.1B | $1.9B | $738M | $593M | |
| Cash From Investing | -$565M | -$762M | -$1B | -$137M | -$148M | |
| Cash From Financing | $385M | -$196M | -$367M | $914M | -$165M | |
| Free Cash Flow | $1.7B | $1.7B | $1.4B | $648M | $483M | |
GEHC
Sector
Market Cap
$36.3B
$25.9M
Price % of 52-Week High
84.15%
51.6%
Dividend Yield
0.18%
0%
Shareholder Yield
-0.04%
-1.66%
1-Year Price Total Return
-9.52%
-18.99%
Beta (5-Year)
--
0.485
Dividend yield:
0.18%
Annualized payout:
$0.12
Payout ratio:
3.59%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$81.99
200-day SMA
Buy
Level
$74.91
Bollinger Bands (100)
Buy
Level
73.63 - 82.83
Chaikin Money Flow
Sell
Level
-1.9M
20-day SMA
Sell
Level
$83.71
Relative Strength Index (RSI14)
Sell
Level
41.84
ADX Line
Sell
Level
7.14
Williams %R
Buy
Level
-87.26
50-day SMA
Sell
Level
$81.34
MACD (12, 26)
Buy
Level
6.36
25-day Aroon Oscillator
Sell
Level
-28
On Balance Volume
Sell
Level
-2.3M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (1.9032)
Sell
CA Score
(Annual)
Level (-1.0273)
Buy
Beneish M-Score
(Annual)
Level (-2.4631)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (0.2594)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Advanced Visualization Solutions segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company’s history roots back to the year 1892 and it was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
Stock Forecast FAQ
In the current month, GEHC has received 10 Buy ratings 6 Hold ratings, and 1 Sell ratings. The GEHC average analyst price target in the past 3 months is $92.00.
-
Where Will GE Healthcare Technologies, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that GE Healthcare Technologies, Inc. share price will rise to $92.00 per share over the next 12 months.
-
What Do Analysts Say About GE Healthcare Technologies, Inc.?
Analysts are divided on their view about GE Healthcare Technologies, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that GE Healthcare Technologies, Inc. is a Sell and believe this share price will drop from its current level to $77.00.
-
What Is GE Healthcare Technologies, Inc.'s Price Target?
The price target for GE Healthcare Technologies, Inc. over the next 1-year time period is forecast to be $92.00 according to 17 Wall Street analysts, 10 of them rate the stock a Buy, 1 rates the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is GEHC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for GE Healthcare Technologies, Inc. is a Buy. 10 of 17 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of GEHC?
You can purchase shares of GE Healthcare Technologies, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase GE Healthcare Technologies, Inc. shares.
-
What Is The GE Healthcare Technologies, Inc. Share Price Today?
GE Healthcare Technologies, Inc. was last trading at $79.79 per share. This represents the most recent stock quote for GE Healthcare Technologies, Inc.. Yesterday, GE Healthcare Technologies, Inc. closed at $79.77 per share.
-
How To Buy GE Healthcare Technologies, Inc. Stock Online?
In order to purchase GE Healthcare Technologies, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get GEHC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GEHC
Sector
P/E ratio
16.49x
23.82x
PEG ratio
0.51x
-0.01x
P/B ratio
3.64x
1.83x
Price / LTM sales
1.81x
1.56x
Growth Metrics
GEHC
Sector
Revenue growth
5.76%
4.18%
Earnings growth
-4.7%
9.66%
Revenue (5-year growth)
3.41%
6.28%
Earnings forecast
$0.99
-$0.18
Profitability
GEHC
Sector
Profitability FY 2024
$8.2B
$3.1M
Return on invested capital
11.74%
-32.89%
Return on assets
6.65%
-29.56%
Return on equity
24.49%
-38.66%
Earnings Date
Last Earnings Date
Oct
29
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Jan
28
Balance Sheet
GEHC
Sector
Total cash
$4B
$25.2M
Short term investments
--
$25.1M
Total assets
$33.1B
$73M
Long term debt
$8.6B
$3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did AMD Stock Go Up?
Since January 9th, shares of chipmaker AMD (NASDAQ:AMD) have been…
Will Data Centers Be In Space?
With demand for data centers seemingly growing by the day,…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
47
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
56
INTC alert for Jan 24
Intel Corp. [INTC] is down 17.01% over the past day.
Buy
64
BNR alert for Jan 24
Burning Rock Biotech Ltd. [BNR] is down 12.81% over the past day.
Sell
19
APGE alert for Jan 24
Apogee Therapeutics, Inc. [APGE] is down 12.28% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
